AMPE - Ampio Pharmaceuticals Stock Trading

Will These Penny Stocks Be On Your Friday Watch List? With the short week coming to an end, some traders will take an inventory of the last few days and assess a few things. First and foremost, taking into account any losses incurred from penny stocks, for instance. If you are doing this right...

Aimmune Therapeutics (NASDAQ: AIMT ) initiated with Neutral rating and $33 (4% upside) price target at H.C. Wainwright. More news on: Aimmune Therapeutics, Inc., Ampio Pharmaceuticals, Inc., Apellis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

ENGLEWOOD, Colo. , Dec. 4, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a   development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled  "Evaluating the Efficacy and Safety of Ampi...